The EXtatin Approach to tattoo removal

  • Topical solution using proprietary nanotech delivery device.

  • Non-disruptive, pain-free, scar-free, simple tattoo removal.

  • Topical solution expected to fully restore tattooed skin.

EXtatin proposes to use patented nanotechnology to deliver EXtatin’s non-disruptive drugs into tattooed skin without pain, thus gaining access to the dermis where proprietary techniques will be implemented to draw tattoos to the skin’s surface, thereby providing a clean slate for individuals wishing to remove their tattoos. In detail, EXtatin will develop a topical cream containing a chemical agent(s) that safely brings trapped tattoos to the surface of the skin from the dermal layer. A patented, advanced nanotechnology device will exclusively be used to painlessly introduce the EXtatin agent(s) to promote release of tattoo art toward or onto the surface whereby tattoos could conceivably simply be wiped off the skin’s surface. EXtatin’s exclusivity agreement with inventor of the unique, highly advanced nanotechnology – who is also an equity shareholder in EXtatin – provides a significant barrier-to-trade for our competition. In addition, based on EXtatin’s confidentiality and exclusivity agreement with the patent holder, no other company or institute has considered nor utilized this protected nanotechnology for the purpose of pain-free, non-ablative tattoo removal.


 

The Solution

EXtatin proposes a simple tattoo removal system of topical, non-corrosive creams, ointments, or patches using a proprietary nanotechnology delivery device that can be commercially accessible to all. A painless, non-scarring, simple, topical tattoo removal technique is not only in demand, but is now possible due to breakthroughs in patented advanced nanotechnology, cell physiology, and molecular biology – knowledge and expertise currently being harnessed by EXtatin, Inc. in association with the nanotechnology patent owner. We will discover natural or synthetic agents that fully restore tattooed skin using rigorous experimental protocols. Molecular Biology pilot techniques will validate project feasibility and discovered agents will be applied to in vitro skin models to either stimulate cell migration. In vivo studies using tattooed hairless animals will test the viability of candidate drugs or combinatorial treatment regimens. Finally, the system will be tested in clinical trials before being approved for franchising, B2B licensing, and more.

EXtatin’s key attributes, which serve to predict a highly successful venture, include the following:

  • –Exclusive use of proprietary nanotech IP: Uniquely effective device to introduce EXtatin’s candidate molecule(s) into skin without epidermal disruption or pain.

  • Unique modality of tattoo removal: Treatment excludes necrotizing toxicity or scar-forming side effects.

  • –Ease-of-use: Tattoos are simply raised to skin’s surface to be effortlessly lifted or wiped away. 

 

Tattoo Removal: State-of-the-Art

At least 8 million tattooed individuals in the US have reported regrets after being tattooed for either pathologic or aesthetic reasons. This number is grossly underestimated, especially since tattooing is on the rise and the art-form is ensconced within popular culture. Moreover, globally, the number of people wishing to remove their tattoos, from today’s youth to baby boomers, is vast. However, these individuals have little recourse since it is axiomatic that commercially available tattoo removal techniques are ineffective, painful, scar-inducing, and expensive. The average cost consumers pay to remove tattoos is $3,000, which often involves multiple treatment sessions. The most popular removal technique, laser therapy, involves multiple expensive sessions to heat-fragment the ink particles and invariably results in significant hypo-/hyperpigmentation owing to widespread necrosis with concomitant burn-induced tissue sloughing and dermal fibrosis or hardened, crusty scarring (see Fig. 5). Painful surgical excision, mechanical and chemical dermabrasion, necrotizing agents, and skin bleaching techniques leave the skin scarred and inflamed. And re-tattooing of the skin with ‘ink softeners’ or ‘flesh-colored’ inks to mask the underlying colored pigments can compound pathologic changes, reopening lesions, reintroducing potentially harmful substances into the dermis.


Competition

EXtatin is one of the top 3 of companies in North America researching innovative tattoo removal methods. EXtatin is unique among its competitors in the innovative tattoo removal research and development space because it is the only company in search a safe, topical removal method using patented nanotechnology.